GoHealth reported a strong Q4 2023, with net revenues of $276.7 million, a net loss of $2.3 million, and Adjusted EBITDA of $57.0 million. The company's focus on consumer engagement and strategic initiatives drove significant improvements in profitability and operating cash flow.
Generated $109.1 million of cash flow from operations in 2023, a 79.2% improvement compared to the prior year.
Non-agency sales accounted for 60% of Medicare revenue in Q4 2023, compared to 26% in 2022, driving cash generation.
Q4 2023 net revenues were $276.7 million, compared to $69.4 million in the prior year period.
Q4 2023 net loss was $2.3 million and Adjusted EBITDA was $57.0 million, improvements of 98.5% and 160.1%, respectively, compared to the prior year period.
No forward guidance was provided in the press release.